| |
...
|
|
| |
 |
Caryolysine®
10 mg
Solution (Vial)
Chlormethine HCL |

|
Vepeside®
50 mg
Vepeside® 100 mg
Soft Capsules Bottle
Sol. Amp. 5 ml
Etoposide
|
| |
 |
 |
 |
|
Indication:
Injectable form: Hodgkin’s disease by polychemiotherapy.
Topic form : Mycosis fungoides, psoriasis for adults
|
Indication:
Treatment of breast and lung cancer, lymphoma, leukaemia, testicular carcinoma
|
|
 |
Ethyol®
50 mg/ml
Lyophilisat
IV
Vial
375 & 500 mg
Amifostine
|
 |
Thiotepa
® 15 mg
Lyophilisat
IV (Vial) Thiothepa
|
 |
 |
 |
| |
| |
| |
Indication:
Radioprotection in head and neck cancers.
Chimioprotection in ovarian carcinoma
(FIGO III or IV)) and solid non-germ tumors |
Indication:
Radioprotection in head and neck cancers.
Chimioprotection in ovarian carcinoma
(FIGO III or IV)) and solid non-germ tumors Indication:
Treatment of ovary, breast and bladder cancer. Used for bone marrow and
stem cells transplantations. |
| |
|
|
|
| |
| Contact
us : |
|
2
Rue Niels Bohr - ZI de l'Esplanade
77400 ST THIBAULT DES VIGNES
FRANCE |
Téléphone
: +33 1 64 12 34 56
Télécopie : +33 1 64 12 37 14
Messagerie : info@genopharm.eu
|